European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028.
The Checkup by Singlecare
AUGUST 29, 2023
Although a generic was approved in 2019, generic apixaban will not be available on the market until at least April 2028. The FDA approved two applications for generic versions of Eliquis by the companies Micro Labs Limited and Mylan Pharmaceuticals, Inc. This is called off-label prescribing. What is Eliquis used for?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
NOVEMBER 27, 2023
billion investment, the company aims to significantly enhance its production capacity, addressing the surging demand for its medicines and potential innovations emerging from its pipeline of drugs for metabolic disorders. With this additional EUR 2.1
pharmaphorum
JANUARY 14, 2021
Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Whatever the challenges, the pharmaceutical industry enters 2021 with a new sense of purpose. Pharma pivots East.
Pharmaceutical Technology
DECEMBER 22, 2022
The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. However, he did point out that the joint assessment could be a useful way of narrowing down typically broad EMA label content to specific patient populations.
Expert insights. Personalized for you.
98 
Let's personalize your content